PCIF1 and glioblastoma: In 2021, a pan-cancer analysis61 of PCIF1 was conducted and revealed significant differential expression of PCIF1 mRNA in most tumors including colon adenocarcinoma, glioblastoma multiforme, stomach adenocarcinoma, and kidney chromophobe, compared with the corresponding adjacent normal tissues.